APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin Sodium

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Selected research

Industry Growth & Trends

Global Heparin Sodium Industry Growth and Trends Forecast to 2032

8 January 2026112 pages

Choose your research edition.

Industry ResearchHeparin Sodium Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Sodium Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Heparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Sodium Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Sodium Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by Europe and North America, total with a share about 35 percent. In terms of application, the largest application is Treatment of Venous Thromboembolism, followed by Cardioversion of Atrial Fibrillation/Flutter, and Treatment of Venous Thromboembolism, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Heparin Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Heparin Sodium market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Heparin Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Heparin Sodium.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Heparin Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Heparin Sodium Market by Company

Shenzhen Hepalink

Bioibérica

Nanjing King-friend

Pfizer

Dongcheng Biochemicals

Changzhou Qianhong Bio-pharma

Changshan Biochemical

Pharma Action

Baxter

Dongying Tiandong Pharmaceutical

Opocrin

Aspen Oss

Xinbai Pharmaceuticals

Yino Pharma Limited

Sichuan Deebio

Heparin Sodium Segment by Type

Oral Type

Injection Type

Heparin Sodium Segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Other

Heparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Heparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Type Table 2. Major Company of Injection Type Table 3. Global Heparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 5. Global Heparin Sodium Sales Market Share in Volume by Type (2021-2026) Table 6. Global Heparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 7. Global Heparin Sodium Sales Market Share in Value by Type (2021-2026) Table 8. Global Heparin Sodium Price by Type (2021-2026) & (USD/Kg) Table 9. Global Heparin Sodium Sales by Type (2027-2032) & (Kg) Table 10. Global Heparin Sodium Sales Market Share in Volume by Type (2027-2032) Table 11. Global Heparin Sodium Sales by Type (2027-2032) & (US$ Million) Table 12. Global Heparin Sodium Sales Market Share in Value by Type (2027-2032) Table 13. Global Heparin Sodium Price by Type (2027-2032) & (USD/Kg) Table 14. North America Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 15. North America Heparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 17. Europe Heparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Heparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 21. Latin America Heparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Heparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 24. Heparin Sodium Industry Trends Table 25. Heparin Sodium Industry Drivers Table 26. Heparin Sodium Industry Opportunities and Challenges Table 27. Heparin Sodium Industry Restraints Table 28. Global Heparin Sodium Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Heparin Sodium Revenue Market Share by Company (2021-2026) Table 30. Global Heparin Sodium Sales by Company (2021-2026) & (Kg) Table 31. Global Heparin Sodium Sales Share by Company (2021-2026) Table 32. Global Heparin Sodium Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Heparin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Heparin Sodium Major Company Production Sites and Headquarters Table 35. Global Heparin Sodium Company, Product Type & Application Table 36. Global Heparin Sodium Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Heparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Heparin Sodium Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Heparin Sodium Sales by Region (2021-2026) & (Kg) Table 41. Global Heparin Sodium Sales Market Share in Volume by Region (2021-2026) Table 42. Global Heparin Sodium Sales by Region (2021-2026) & (US$ Million) Table 43. Global Heparin Sodium Sales Market Share in Value by Region (2021-2026) Table 44. Global Heparin Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Heparin Sodium Sales by Region (2027-2032) & (Kg) Table 46. Global Heparin Sodium Sales Market Share in Volume by Region (2027-2032) Table 47. Global Heparin Sodium Sales by Region (2027-2032) & (US$ Million) Table 48. Global Heparin Sodium Sales Market Share in Value by Region (2027-2032) Table 49. Global Heparin Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Heparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 52. Global Heparin Sodium Sales Market Share in Volume by Application (2021-2026) Table 53. Global Heparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 54. Global Heparin Sodium Sales Market Share in Value by Application (2021-2026) Table 55. Global Heparin Sodium Price by Application (2021-2026) & (USD/Kg) Table 56. Global Heparin Sodium Sales by Application (2027-2032) & (Kg) Table 57. Global Heparin Sodium Sales Market Share in Volume by Application (2027-2032) Table 58. Global Heparin Sodium Sales by Application (2027-2032) & (US$ Million) Table 59. Global Heparin Sodium Sales Market Share in Value by Application (2027-2032) Table 60. Global Heparin Sodium Price by Application (2027-2032) & (USD/Kg) Table 61. North America Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 62. North America Heparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 64. Europe Heparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Heparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 68. Latin America Heparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Heparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 71. Shenzhen Hepalink Company Information Table 72. Shenzhen Hepalink Business Overview Table 73. Shenzhen Hepalink Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Shenzhen Hepalink Heparin Sodium Product Portfolio Table 75. Shenzhen Hepalink Recent Development Table 76. Bioibérica Company Information Table 77. Bioibérica Business Overview Table 78. Bioibérica Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Bioibérica Heparin Sodium Product Portfolio Table 80. Bioibérica Recent Development Table 81. Nanjing King-friend Company Information Table 82. Nanjing King-friend Business Overview Table 83. Nanjing King-friend Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Nanjing King-friend Heparin Sodium Product Portfolio Table 85. Nanjing King-friend Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Pfizer Heparin Sodium Product Portfolio Table 90. Pfizer Recent Development Table 91. Dongcheng Biochemicals Company Information Table 92. Dongcheng Biochemicals Business Overview Table 93. Dongcheng Biochemicals Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Dongcheng Biochemicals Heparin Sodium Product Portfolio Table 95. Dongcheng Biochemicals Recent Development Table 96. Changzhou Qianhong Bio-pharma Company Information Table 97. Changzhou Qianhong Bio-pharma Business Overview Table 98. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio Table 100. Changzhou Qianhong Bio-pharma Recent Development Table 101. Changshan Biochemical Company Information Table 102. Changshan Biochemical Business Overview Table 103. Changshan Biochemical Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Changshan Biochemical Heparin Sodium Product Portfolio Table 105. Changshan Biochemical Recent Development Table 106. Pharma Action Company Information Table 107. Pharma Action Business Overview Table 108. Pharma Action Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Pharma Action Heparin Sodium Product Portfolio Table 110. Pharma Action Recent Development Table 111. Baxter Company Information Table 112. Baxter Business Overview Table 113. Baxter Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Baxter Heparin Sodium Product Portfolio Table 115. Baxter Recent Development Table 116. Dongying Tiandong Pharmaceutical Company Information Table 117. Dongying Tiandong Pharmaceutical Business Overview Table 118. Dongying Tiandong Pharmaceutical Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio Table 120. Dongying Tiandong Pharmaceutical Recent Development Table 121. Opocrin Company Information Table 122. Opocrin Business Overview Table 123. Opocrin Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. Opocrin Heparin Sodium Product Portfolio Table 125. Opocrin Recent Development Table 126. Aspen Oss Company Information Table 127. Aspen Oss Business Overview Table 128. Aspen Oss Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 129. Aspen Oss Heparin Sodium Product Portfolio Table 130. Aspen Oss Recent Development Table 131. Xinbai Pharmaceuticals Company Information Table 132. Xinbai Pharmaceuticals Business Overview Table 133. Xinbai Pharmaceuticals Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 134. Xinbai Pharmaceuticals Heparin Sodium Product Portfolio Table 135. Xinbai Pharmaceuticals Recent Development Table 136. Yino Pharma Limited Company Information Table 137. Yino Pharma Limited Business Overview Table 138. Yino Pharma Limited Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 139. Yino Pharma Limited Heparin Sodium Product Portfolio Table 140. Yino Pharma Limited Recent Development Table 141. Sichuan Deebio Company Information Table 142. Sichuan Deebio Business Overview Table 143. Sichuan Deebio Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 144. Sichuan Deebio Heparin Sodium Product Portfolio Table 145. Sichuan Deebio Recent Development Table 146. North America Heparin Sodium Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. North America Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 148. North America Heparin Sodium Sales Market Share by Country (2021-2026) Table 149. North America Heparin Sodium Sales Forecast by Country (2027-2032) & (Kg) Table 150. North America Heparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 151. North America Heparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Heparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Heparin Sodium Market Share by Country (2021-2026) Table 154. North America Heparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Heparin Sodium Market Share Forecast by Country (2027-2032) Table 156. Europe Heparin Sodium Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Europe Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 158. Europe Heparin Sodium Sales Market Share by Country (2021-2026) Table 159. Europe Heparin Sodium Sales Forecast by Country (2027-2032) & (Kg) Table 160. Europe Heparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Heparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Heparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Heparin Sodium Market Share by Country (2021-2026) Table 164. Europe Heparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Heparin Sodium Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Heparin Sodium Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 168. Asia-Pacific Heparin Sodium Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Heparin Sodium Sales Forecast by Country (2027-2032) & (Kg) Table 170. Asia-Pacific Heparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Heparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Heparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Heparin Sodium Market Share by Country (2021-2026) Table 174. Asia-Pacific Heparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Heparin Sodium Market Share Forecast by Country (2027-2032) Table 176. Latin America Heparin Sodium Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Latin America Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 178. Latin America Heparin Sodium Sales Market Share by Country (2021-2026) Table 179. Latin America Heparin Sodium Sales Forecast by Country (2027-2032) & (Kg) Table 180. Latin America Heparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Heparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Heparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Heparin Sodium Market Share by Country (2021-2026) Table 184. Latin America Heparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Heparin Sodium Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Heparin Sodium Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 188. Middle East and Africa Heparin Sodium Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Heparin Sodium Sales Forecast by Country (2027-2032) & (Kg) Table 190. Middle East and Africa Heparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Heparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Heparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Heparin Sodium Market Share by Country (2021-2026) Table 194. Middle East and Africa Heparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Heparin Sodium Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Heparin Sodium Distributors List Table 199. Heparin Sodium Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Heparin Sodium Image Figure 2. Global Heparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Heparin Sodium Sales (2021-2032) & (Kg) Figure 5. Oral Type Image Figure 6. Global Oral Type Sales YoY Growth (2021-2032) & (Kg) Figure 7. Injection Type Image Figure 8. Global Injection Type Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Heparin Sodium Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Heparin Sodium Market Share by Type 2025 VS 2032 Figure 11. North America Heparin Sodium Sales Market Share in Volume by Type in 2025 Figure 12. North America Heparin Sodium Sales Market Share in Value by Type in 2025 Figure 13. Europe Heparin Sodium Sales Market Share in Volume by Type in 2025 Figure 14. Europe Heparin Sodium Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Heparin Sodium Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Heparin Sodium Sales Market Share in Value by Type in 2025 Figure 17. Latin America Heparin Sodium Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Heparin Sodium Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Heparin Sodium Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Heparin Sodium Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Heparin Sodium Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Treatment of Venous Thromboembolism Image Figure 24. Global Treatment of Venous Thromboembolism Sales YoY Growth (2021-2032) & (Kg) Figure 25. Complications of Pregnancy Image Figure 26. Global Complications of Pregnancy Sales YoY Growth (2021-2032) & (Kg) Figure 27. Cardioversion of Atrial Fibrillation/Flutter Image Figure 28. Global Cardioversion of Atrial Fibrillation/Flutter Sales YoY Growth (2021-2032) & (Kg) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Heparin Sodium Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Heparin Sodium Market Share by Application 2025 VS 2032 Figure 33. North America Heparin Sodium Sales Market Share in Volume by Application in 2025 Figure 34. North America Heparin Sodium Sales Market Share in Value by Application in 2025 Figure 35. Europe Heparin Sodium Sales Market Share in Volume by Application in 2025 Figure 36. Europe Heparin Sodium Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Heparin Sodium Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Heparin Sodium Sales Market Share in Value by Application in 2025 Figure 39. Latin America Heparin Sodium Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Heparin Sodium Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Heparin Sodium Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Heparin Sodium Sales Market Share in Value by Application in 2025 Figure 43. North America Heparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Heparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Heparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Heparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Heparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Heparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Heparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Heparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Heparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Heparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Heparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Heparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Heparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Heparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Heparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Heparin Sodium Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Heparin Sodium Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type
  • Injection Type
Applications
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Other
Companies covered
  • Shenzhen Hepalink
  • Bioibérica
  • Nanjing King-friend
  • Pfizer
  • Dongcheng Biochemicals
  • Changzhou Qianhong Bio-pharma
  • Changshan Biochemical
  • Pharma Action
  • Baxter
  • Dongying Tiandong Pharmaceutical
  • Opocrin
  • Aspen Oss
  • Xinbai Pharmaceuticals
  • Yino Pharma Limited
  • Sichuan Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Heparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Heparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Heparin Sodium Market by Type
  6. 1.3.1 Oral Type
  7. 1.3.2 Injection Type
  8. 1.4 Global Heparin Sodium Market Size by Type
  9. 1.4.1 Global Heparin Sodium Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Heparin Sodium Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Heparin Sodium Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Heparin Sodium Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Heparin Sodium Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Heparin Sodium Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Heparin Sodium Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Heparin Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Heparin Sodium Industry Trends
  2. 2.2 Heparin Sodium Industry Drivers
  3. 2.3 Heparin Sodium Industry Opportunities and Challenges
  4. 2.4 Heparin Sodium Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Heparin Sodium Revenue (2021-2026)
  2. 3.2 Global Top Players by Heparin Sodium Sales (2021-2026)
  3. 3.3 Global Top Players by Heparin Sodium Price (2021-2026)
  4. 3.4 Global Heparin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heparin Sodium Major Company Production Sites & Headquarters
  6. 3.6 Global Heparin Sodium Company, Product Type & Application
  7. 3.7 Global Heparin Sodium Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Heparin Sodium Tier 1, Tier 2, and Tier 3
4 Heparin Sodium Regional Status and Outlook
  1. 4.1 Global Heparin Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Heparin Sodium Historic Market Size by Region
  3. 4.2.1 Global Heparin Sodium Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Heparin Sodium Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Heparin Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Heparin Sodium Forecasted Market Size by Region
  7. 4.3.1 Global Heparin Sodium Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Heparin Sodium Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Heparin Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Heparin Sodium by Application
  1. 5.1 Heparin Sodium Market by Application
  2. 5.1.1 Treatment of Venous Thromboembolism
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Cardioversion of Atrial Fibrillation/Flutter
  5. 5.1.4 Other
  6. 5.2 Global Heparin Sodium Market Size by Application
  7. 5.2.1 Global Heparin Sodium Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Heparin Sodium Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Heparin Sodium Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Heparin Sodium Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Heparin Sodium Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Heparin Sodium Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Heparin Sodium Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Heparin Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shenzhen Hepalink
  2. 6.1.1 Shenzhen Hepalink Company Information
  3. 6.1.2 Shenzhen Hepalink Business Overview
  4. 6.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shenzhen Hepalink Heparin Sodium Product Portfolio
  6. 6.1.5 Shenzhen Hepalink Recent Developments
  7. 6.2 Bioibérica
  8. 6.2.1 Bioibérica Company Information
  9. 6.2.2 Bioibérica Business Overview
  10. 6.2.3 Bioibérica Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bioibérica Heparin Sodium Product Portfolio
  12. 6.2.5 Bioibérica Recent Developments
  13. 6.3 Nanjing King-friend
  14. 6.3.1 Nanjing King-friend Company Information
  15. 6.3.2 Nanjing King-friend Business Overview
  16. 6.3.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nanjing King-friend Heparin Sodium Product Portfolio
  18. 6.3.5 Nanjing King-friend Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Heparin Sodium Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Dongcheng Biochemicals
  26. 6.5.1 Dongcheng Biochemicals Company Information
  27. 6.5.2 Dongcheng Biochemicals Business Overview
  28. 6.5.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dongcheng Biochemicals Heparin Sodium Product Portfolio
  30. 6.5.5 Dongcheng Biochemicals Recent Developments
  31. 6.6 Changzhou Qianhong Bio-pharma
  32. 6.6.1 Changzhou Qianhong Bio-pharma Company Information
  33. 6.6.2 Changzhou Qianhong Bio-pharma Business Overview
  34. 6.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
  36. 6.6.5 Changzhou Qianhong Bio-pharma Recent Developments
  37. 6.7 Changshan Biochemical
  38. 6.7.1 Changshan Biochemical Company Information
  39. 6.7.2 Changshan Biochemical Business Overview
  40. 6.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changshan Biochemical Heparin Sodium Product Portfolio
  42. 6.7.5 Changshan Biochemical Recent Developments
  43. 6.8 Pharma Action
  44. 6.8.1 Pharma Action Company Information
  45. 6.8.2 Pharma Action Business Overview
  46. 6.8.3 Pharma Action Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pharma Action Heparin Sodium Product Portfolio
  48. 6.8.5 Pharma Action Recent Developments
  49. 6.9 Baxter
  50. 6.9.1 Baxter Company Information
  51. 6.9.2 Baxter Business Overview
  52. 6.9.3 Baxter Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Baxter Heparin Sodium Product Portfolio
  54. 6.9.5 Baxter Recent Developments
  55. 6.10 Dongying Tiandong Pharmaceutical
  56. 6.10.1 Dongying Tiandong Pharmaceutical Company Information
  57. 6.10.2 Dongying Tiandong Pharmaceutical Business Overview
  58. 6.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
  60. 6.10.5 Dongying Tiandong Pharmaceutical Recent Developments
  61. 6.11 Opocrin
  62. 6.11.1 Opocrin Company Information
  63. 6.11.2 Opocrin Business Overview
  64. 6.11.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Opocrin Heparin Sodium Product Portfolio
  66. 6.11.5 Opocrin Recent Developments
  67. 6.12 Aspen Oss
  68. 6.12.1 Aspen Oss Company Information
  69. 6.12.2 Aspen Oss Business Overview
  70. 6.12.3 Aspen Oss Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aspen Oss Heparin Sodium Product Portfolio
  72. 6.12.5 Aspen Oss Recent Developments
  73. 6.13 Xinbai Pharmaceuticals
  74. 6.13.1 Xinbai Pharmaceuticals Company Information
  75. 6.13.2 Xinbai Pharmaceuticals Business Overview
  76. 6.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
  78. 6.13.5 Xinbai Pharmaceuticals Recent Developments
  79. 6.14 Yino Pharma Limited
  80. 6.14.1 Yino Pharma Limited Company Information
  81. 6.14.2 Yino Pharma Limited Business Overview
  82. 6.14.3 Yino Pharma Limited Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Yino Pharma Limited Heparin Sodium Product Portfolio
  84. 6.14.5 Yino Pharma Limited Recent Developments
  85. 6.15 Sichuan Deebio
  86. 6.15.1 Sichuan Deebio Company Information
  87. 6.15.2 Sichuan Deebio Business Overview
  88. 6.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sichuan Deebio Heparin Sodium Product Portfolio
  90. 6.15.5 Sichuan Deebio Recent Developments
7 North America by Country
  1. 7.1 North America Heparin Sodium Sales by Country
  2. 7.1.1 North America Heparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Heparin Sodium Sales by Country (2021-2026)
  4. 7.1.3 North America Heparin Sodium Sales Forecast by Country (2027-2032)
  5. 7.2 North America Heparin Sodium Market Size by Country
  6. 7.2.1 North America Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Heparin Sodium Market Size by Country (2021-2026)
  8. 7.2.3 North America Heparin Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Heparin Sodium Sales by Country
  2. 8.1.1 Europe Heparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Heparin Sodium Sales by Country (2021-2026)
  4. 8.1.3 Europe Heparin Sodium Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Heparin Sodium Market Size by Country
  6. 8.2.1 Europe Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Heparin Sodium Market Size by Country (2021-2026)
  8. 8.2.3 Europe Heparin Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Heparin Sodium Sales by Country
  2. 9.1.1 Asia-Pacific Heparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Heparin Sodium Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Heparin Sodium Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Heparin Sodium Market Size by Country
  6. 9.2.1 Asia-Pacific Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Heparin Sodium Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Heparin Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Heparin Sodium Sales by Country
  2. 10.1.1 South America Heparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Heparin Sodium Sales by Country (2021-2026)
  4. 10.1.3 South America Heparin Sodium Sales Forecast by Country (2027-2032)
  5. 10.2 South America Heparin Sodium Market Size by Country
  6. 10.2.1 South America Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Heparin Sodium Market Size by Country (2021-2026)
  8. 10.2.3 South America Heparin Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Heparin Sodium Sales by Country
  2. 11.1.1 Middle East and Africa Heparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Heparin Sodium Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Heparin Sodium Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Heparin Sodium Market Size by Country
  6. 11.2.1 Middle East and Africa Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Heparin Sodium Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Heparin Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Heparin Sodium Value Chain Analysis
  2. 12.1.1 Heparin Sodium Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Heparin Sodium Production Mode & Process
  7. 12.2 Heparin Sodium Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Heparin Sodium Distributors
  10. 12.2.3 Heparin Sodium Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst